Social Work Assistance and Stipends for Housing (SASH)

NCT05803603 | Completed Results

• 1 other identifier: HP-00100771
• Study Type: interventional
• Target: 8
• Locations: 1 country
• Sites: 1

Brief Summary

SASH is a clinical trial feasibility study that will provide an intervention to improve Opioid Use Disorder (OUD), Quality of Life (QOL), and housing outcomes for homeless patients receiving Medication for Opiate Use Disorder (MOUD). The main questions of the study are does a $500 housing stipend for individuals on MOUD increase treatment retention, improved quality of life and prevent homelessness.

Conditions

Opioid-Related Disorders; Housing Problems

Outcome Measures

Primary Outcomes (24)

• Methadone Doses

  Percentage of Missed Methadone Doses, Range 0 - 100%, Lower percentages mean better outcome.

  3 months prior to enrollment

• Methadone Doses

  Percentage of Missed Methadone Doses, Range 0 - 100%, Lower percentages mean better outcome.

  3-6 months post enrollment

• Methadone Doses

  Percentage of Missed Methadone Doses, Range 0 - 100%, Lower percentages mean better outcome.

  9-12 months post enrollment.

• OUD Checklist Scores

  Scores on the Diagnostic and Statistical Manual V OUD checklist. Range 0 - 13. Higher scores mean worse outcome with 2-3 as mild severity, 4-5 moderate severity and 6 or more as severe.

  Baseline

• OUD Checklist Scores

  Scores on the Diagnostic and Statistical Manual V OUD checklist. Range 0 - 13. Higher scores mean worse outcome with 2-3 as mild severity, 4-5 moderate severity and 6 or more as severe.

  6 months

• OUD Checklist Scores

  Scores on the Diagnostic and Statistical Manual V OUD checklist. Range 0 - 13. Higher scores mean worse outcome with 2-3 as mild severity, 4-5 moderate severity and 6 or more as severe.

  12 months

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Three months prior to enrollment

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 1

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 2

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 3

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 4

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 5

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 6

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 7

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 8

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 9

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 10

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 11

• Urine Toxicology Tests

  Detection of positive urine toxicology tests collected from chart reviews. Values are positive or negative for controlled substances. Positive test the worse outcome

  Month 12

• Quality of Life Scores

  SF-36 scores 0 (worst) to 100 (best)

  Baseline

• Quality of Life Scores

  SF-36 scores 0 (worst) to 100 (best)

  6 Month

• Quality of Life Scores

  SF-36 scores 0 (worst) to 100 (best)

  12 Month

• Housed vs Unhoused at 6 Months

  Count of participants that are housed at 6 months

  6 Months

• Housed vs Unhoused at 6 Months

  Count of housed at 12 month

  12 Months

Study Arms (1)

Intervention Arm

EXPERIMENTAL

Individuals will receive $500 monthly stipend for the first months of the study and will receive twelve months of social work supports to help individuals find permanent housing.

Behavioral: Stipend and Social Work Supports

Interventions

Stipend and Social Work Supports BEHAVIORAL

Same as arm description

Intervention Arm

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Experienced homelessness during at least 15 of the 30 days preceding enrollment
• Is a patient at the University of Maryland Addiction Treatment Program (ATP) receiving methadone treatment.

Sponsors & Collaborators

• University of Maryland, Baltimore: lead

Study Sites (1)

University of Maryland Addiction Treatment Program (ATP)

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related Disorders; Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders

Results Point of Contact

• Title: Jay Unick
• Organization: University of Maryland School of Social Work

junick@ssw.umaryland.edu

410-706-3735

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Model Details: 8 individuals will be recruited and followed for 12 months following the intervention. The intervention includes providing a $500 monthly housing stipend for six months and twelve months of social work support to find permanent housing. Individuals will be asked to provide information thought interviews and clinical records.

Study Record Dates

• First Submitted: March 23, 2023
• First Posted: April 7, 2023
• Study Start: December 1, 2022
• Primary Completion: January 1, 2024
• Study Completion: January 1, 2024
• Last Updated: April 18, 2025
• Results First Posted: April 18, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: The data will be available at the end of the study period for 5 years.
• Access Criteria: Access criteria to be determined.

Locations

US (1)